Peter de Nully Brown

Peter de Nully Brown

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 4 out of 4Page size: 500
  1. 2010
  2. Published

    Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

    Dillner, J., Kjaer, S. K., Wheeler, C. M., Sigurdsson, K., Iversen, O., Hernandez-Avila, M., Perez, G., Brown, Peter de Nully, Koutsky, L. A., Tay, E. H., García, P., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S., Tang, G. W. K., Ferris, D. G., Paavonen, J., Lehtinen, M., Steben, M., Bosch, F. X., Joura, E. A., Majewski, S., Muñoz, N., Myers, E. R., Villa, L. L., Taddeo, F. J., Roberts, C., Tadesse, A., Bryan, J. T., Maansson, R., Lu, S., Vuocolo, S., Hesley, T. M., Barr, E., Haupt, R. & FUTURE I/II Study Group, F. I. S. G., 1 Jan 2010, In: BMJ - British Medical Journal - Clinical Research Edition. 341, p. c3493

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

    Geisler, C. H., Kolstad, A., Laurell, A., Räty, R., Jerkeman, M., Eriksson, M., Nordström, M., Kimby, E., Boesen, A. M., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G. F., Ralfkiaer, E., Ehinger, M., Sundström, C., Delabie, J., Karjalainen-Lindsberg, M., Brown, Peter de Nully, Elonen, E. & Nordic Lymphoma Group, N. L. G., 25 Feb 2010, In: Blood. 115, 8, p. 1530-3 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

    Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, Peter de Nully, Koutsky, L. A., Tay, E. H., Garcia, P. J., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S., Tang, G. W. K., Ferris, D. G., Paavonen, J., Steben, M., Bosch, F. X., Dillner, J., Huh, W. K., Joura, E. A., Kurman, R. J., Majewski, S., Myers, E. R., Villa, L. L., Taddeo, F. J., Roberts, C., Tadesse, A., Bryan, J. T., Lupinacci, L. C., Giacoletti, K. E. D., Sings, H. L., James, M. K., Hesley, T. M., Barr, E. & Haupt, R. M., 3 Mar 2010, In: National Cancer Institute. Journal (Online). 102, 5, p. 325-39 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Reasons for treating secondary AML as de novo AML

    Ostgård, L. S. G., Kjeldsen, E., Holm, M. S., Brown, Peter de Nully, Pedersen, B. B., Bendix, K., Johansen, P., Kristensen, J. S. & Nørgaard, J. M., 1 Sep 2010, In: European Journal of Haematology. 85, 3, p. 217-26 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 165119349